Drug therapy for rheumatoid arthritis;Die medikamentöse behandlung der rheumatoiden arthritis

Orthopade

Volumn 32, Issue 12, 2003, Pages 1095-1103

  Arndt, U ^a   Rittmeister, M ^a   Moller B ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

DMARD; Medication; Rheumatoid arthritis; Treatment

Indexed keywords

ANALGESIC AGENT; ANTIRHEUMATIC AGENT; AUROTHIOGLUCOSE; AUROTHIOMALATE; AZATHIOPRINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; GOLD SALT; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR BLOCKER; UNCLASSIFIED DRUG;

DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; EARLY DIAGNOSIS; HUMAN; LONG TERM CARE; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; SYMPTOM;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CONTROLLED CLINICAL TRIALS; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0346749600     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-003-0560-9     Document Type: Review

References (39)

1. American College of rheumatology ad hoc committee on clinical guidelines (1996) Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 39: 713-722
2. Boers M (1999) The case for corticoidsteroids in the treatment of early rheumatoid arthritis. Rheumatology 38: 95-102
3. Bresnihan B, Alvaro-Gracia JM, Cobby M et al. (1998) Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41: 2196-2204
4. Bridges SL Jr, Lopez-Mendez A, Han KH, Tracy IC, Alarcon GS (1991) Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 18: 984-988
5. Cannon GW (1997) Methotrexate pulmonary toxicity. Rheum Dis Clin North Am 23: 917-937
6. Felson DT, Anderson JJ, Boers M et al. (1995) American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38: 727-735
7. Frazer TN (1945) Gold treatment in rheumatoid arthritis. Ann Rheum Dis 4: 71
8. Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, Vinh DC (2003) Anti-tumor necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3: 148-155
9. Grennan DM, Gray J, Loudon J, Fear S (2001) Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60: 214-217
10. Hench PS, Kendall EC, Slocumb CH, Polley HF (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocortisone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 24: 181-197
11. Joint Committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, ACTH, and other therapeutic measures in chronic rheumatic diseases (1960) A comparison of prednisolone with aspirin or other analgetics in the treatment of rheumatoid arthritis. Ann Rheum Dis 19: 331-337
12. Keysser M, Keysser C, Neumann S, Schuhr EU, Kruse R (1989) Wound infection following surgical intervention for rheumatism and its relationship to preoperative basic therapy. Beitr Orthop Traumatol 36: 424-428
13. Kirwan J, Byron M, Watt I (2001) The relationship between soft tissue swelling, joint space narrowing and erosive damage in hand X-ray of patients with rheumatoid arthritis. Rheumatology 40: 297-301
14. Kirwan JR and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group (1995)The effect of glucocorticoids onjoint destruction in rheumatoid arthritis. N Engl J Med 333: 142-146
15. Landewe RB, Boers M, Verhoeven AC et al. (2002) COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 46: 347-356
16. Larsen A, Dale K, Eek M (1987) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol 18: 481-491
17. Maksymowych W, Russel AS (1987) Antimalarials in rheumatology: efficacy and safety. Sem Arthritis Rheum 16: 206-221
18. Mau W, Zink A (2000) Epidemiologie. In: Rau R (ed): Basistherapie der rheumatoiden Arthritis. UNI-MED, Bremen, S 24-32
19. Menninger H (2000) Kombinationstherapie. In: Rau R (ed): Basistherapie der rheumatoiden Arthritis. UNI-MED, Bremen, S 298-329
20. Möller B (2003) Systemische Therapie mit Glukokortikoiden: Behandlung rheumatischer Erkrankungen. Pharm unserer Zeit 32: 302-305
21. Moreland LW, O'Dell JR (2002) Glucocorticoids and rheumatoid arthritis. Arthritis Rheum 46: 2553-2563
22. Nuki G, Bresnihan B, Bear MB, McCabe D, European Group of Clinical Investigators (2002) Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46: 2838-2846
23. O'Dell JR (2001) TNF-alpha inhibition: the need for a tumor necrosis factor thermostat. Mayo Clin Proc 76: 573-775
24. O'Dell JR, Leff R, Paulsen G et al. (2003) Treatment of rheumatoid arthritis with methotrexate and hydroxy-chloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46: 1164-1170
25. Ostensen M (1994) Optimisation of antirheumatic drug treatment in pregnancy. Clin Pharmakokinet 27: 486-503
26. Perhala RS, Wilke WS, Clough JD, Segal AM (1991) Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 34: 146-152
27. Pincus T, Marcum SB, Callahan LF (1992) Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol 19: 1885-1894
28. Porter d, McInnes I, Hunter JA, Capell HA (1994) Outcome of second-line therapy in rheumatoid arthritis. Ann Rheum Dis 53: 812-815
29. Rau R, Herborn G, Koch A, Werdier D (1987) Aspekte der Langzeitbeobachtung von Patienten mit chronischer Polyarthritis unter parenteraler Goldbehandlung. Akt Rheumatol 12: 181-189
30. Rau R, Wassenberg S, Zeidler H, LDPT-Study Group (2000) Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthitis - preliminary results of a multicenter, randomized, parallel, double blind study. Z Rheumatol 59 (Suppl 2): 90-96
31. Sharp JT (1971) Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Arthritis Rheum 14: 706-720
32. Smolen JS, Kalden JR, Scott DL et al. (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. Lancet 353: 259-266
33. Smolen JS, Steiner G (2003) Therapeutic stragtegies for rheumatoid arthritis. Nature Rev 2: 473-488
34. Strand V, Cohen S, Schiff M et al. (1999) Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 159: 2542-2550
35. Ten Wolde S, Breedveld FC, Hermans J et al. (1996) Randomized placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet 347: 347-352
36. Van der Heide A, Jacobs JW, Bijlsma JW et al. (1996) The effectiveness of early treatment with 'second-line' anti-rheumatic drugs: a randomized, controlled trial. Ann Intern Med 124: 699-707
37. van der Heijde DMFM, van't Hof MA, van Riel PLCM, van de Putte LBA (1993) Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 20: 579-581
38. Van Ede AE, Laan RF, Rood MJ et al. (2001) Effect of folic and folinic acid supplementation on toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 44: 1515-1524
39. Walker AM, Funch D, Dreyer NA, Tolman KG, Kremer JM, Alarcon GS, Lee RG, Weinblatt ME (1993) Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis Rheum 36: 329-335